Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Igf2 regulates early postnatal DPP4 + preadipocyte pool expansion.

Altun I., Vo KHD., Walia S., Yan X., Singh I., Karlina R.

Animal Study, published in Genes Dev (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Genes Dev (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40930990
PMCID
PMC12667387
DOI
10.1101/gad.352710.125
Citations
1

Abstract (original English)

Adipose tissue is rapidly expanding early in life. Elucidating the queues facilitating this process will advance our understanding of metabolically healthy obesity. Using single-cell RNA sequencing, we identified compositional differences of prewean and adult murine subcutaneous adipose tissue. We identified a dipeptidyl peptidase-4 ( Dpp4 )-positive precursor population residing in the reticular interstitium of subcutaneous adipose expressing insulin growth factor 2 ( Igf2 ) in prewean mice. We show that IGF2 drives proliferation rather than differentiation in these cells. Moreover, loss of Igf2 in Dpp4 + progenitor cells promotes adipogenesis. Our findings unravel the temporally restricted expression of Igf2 to promote preadipocyte expansion.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMiceInsulin-Like Growth Factor IIAdipogenesisAdipocytesDipeptidyl Peptidase 4Cell ProliferationMice, Inbred C57BLStem CellsSubcutaneous Fat

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.